At Hetero, we believe that our expertise has to be leveraged for greater good. With the diverse range of generics across therapies in our product portfolio, Hetero has been realizing its organizational goal of bringing high-quality medicines through branded generics, specifically targeting emerging markets such as Latin America, Asia, Africa, CIS and other key countries.
Our product portfolio consists of more than 200 branded generic products spanning across key therapies such as Oncology, Cardiology, Central Nervous System, ARVs, Hepatology and few others.
The company is strengthening its front-end presence in each market by establishing strong distribution networks and specialized sales force, reaching out to doctors and patients.
Branded generics division is intended to bring access to high-quality medicines within affordable reach of markets across the globe.